Jennifer C Spencer
Biographic Data
| ID | 5224940 |
|---|---|
| NAME | Jennifer C Spencer |
| GIVEN NAMES | Jennifer C |
| FAMILY NAME | Spencer |
| SIGNATURE | SPENCER J C |
| AFFILIATIONS | The University of Texas at Austin |
| ORCID | 0000-0001-9508-1525 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Many hops, many stops
Background: The burden of Non-Communicable Diseases (NCDs) in urban informal settlements across Lower and Middle Income Countries is increasing. In recognition, there has been interest in fine-tuning policies on NCDs to meet the unique needs of people living in these settlements. To inform such policy efforts, we studied the care-seeking journeys of people living in urban informal settlements for two NCDs-diabetes and hypertension. The study was …
Barriers to Cervical Cancer Screening by Sexual Orientation Among Low-Income Women in North Carolina
We sought to examine cervical cancer screening barriers by sexual orientation among low-income women in North Carolina. The MyBodyMyTest-3 Trial recruited low-income women ( n = 70) to straight/heterosexual women ( n = 683). For both LGBQ and straight respondents, the greatest barriers to screening were lack of health insurance (63% and 66%) and cost (49% and 50%). LGBQ respondents were more likely than straight respondents to report forgetting t…
Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients
Objectives. To assess predictors of timely human papillomavirus (HPV) vaccine follow-through among privately insured individuals initiating the 3-dose series. Methods. Using MarketScan Commercial claims data, we identified 1 332 217 privately insured US individuals aged 9 to 26 years who initiated the bivalent or quadrivalent HPV vaccine series from 2006 to 2014, with follow-up data extending through 2015. The study outcome was receipt of third H…
No prominent works on this page.
Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients
Objectives. To assess predictors of timely human papillomavirus (HPV) vaccine follow-through among privately insured individuals initiating the 3-dose series. Methods. Using MarketScan Commercial claims data, we identified 1 332 217 privately insured US individuals aged 9 to 26 years who initiated the bivalent or quadrivalent HPV vaccine series from 2006 to 2014, with follow-up data extending through 2015. The study outcome was receipt of third H…
Many hops, many stops
Background: The burden of Non-Communicable Diseases (NCDs) in urban informal settlements across Lower and Middle Income Countries is increasing. In recognition, there has been interest in fine-tuning policies on NCDs to meet the unique needs of people living in these settlements. To inform such policy efforts, we studied the care-seeking journeys of people living in urban informal settlements for two NCDs-diabetes and hypertension. The study was …
Barriers to Cervical Cancer Screening by Sexual Orientation Among Low-Income Women in North Carolina
We sought to examine cervical cancer screening barriers by sexual orientation among low-income women in North Carolina. The MyBodyMyTest-3 Trial recruited low-income women ( n = 70) to straight/heterosexual women ( n = 683). For both LGBQ and straight respondents, the greatest barriers to screening were lack of health insurance (63% and 66%) and cost (49% and 50%). LGBQ respondents were more likely than straight respondents to report forgetting t…
Medicine (3 works) · Cancer (2 works) · Cervical cancer (2 works) · Cervical Cancer and HPV Research (2 works) · Demography (2 works) · Environmental health (2 works) · Family medicine (2 works) · Cervical cancer screening (1 works) · Diabetes Management and Education (1 works) · Diabetes mellitus (1 works)